Commitments and Contingencies (Details)	1 Months Ended		3 Months Ended
	Jan. 31, 2020 USD ($)	Sep. 30, 2014 USD ($) shares	Mar. 31, 2021 USD ($) m² $ / shares	Mar. 31, 2020 shares
Commitments and Contingencies (Details) [Line Items]
Commitments related to agreements			$ 450,000
Maximum payment for commitment milestones			$ 7,900,000
Percentage for royalties			6.00%
Office space (in Square Meters) | m²			6,200
Cash paid to acquire Hy Biopharma intangible asset		$ 275,000
Issuance of shares for assets (in shares) | shares		184,912
Fair value of shares issued in connection with Hy BioPharma asset purchase		$ 3.75
Shares exercisable (in shares) | shares				1,956,182
Effective price per share (in Dollars per share) | $ / shares			$ 2.56
Additional Payments			$ 5,000,000.0
Ownership of company outstanding			19.90%
Minimum [Member]
Commitments and Contingencies (Details) [Line Items]
Authorized shares to be issued	$ 5,000
Maximum [Member]
Commitments and Contingencies (Details) [Line Items]
Authorized shares to be issued	$ 500,000